NICOTINAMIDE

Clinical trials for NICOTINAMIDE explained in plain language.

Never miss a new study

Get alerted when new NICOTINAMIDE trials appear

Sign up with your email to follow new studies for NICOTINAMIDE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Vitamin B3 trial aims to halt liver damage

Disease control Recruiting now

This study is testing whether a form of vitamin B3 called nicotinamide can stop or even reverse liver scarring (fibrosis) in people with fatty liver disease. About 30 overweight or obese adults will take either nicotinamide or a placebo pill daily for one year. Researchers will u…

Matched conditions: NICOTINAMIDE

Phase: PHASE2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

NICOTINAMIDE

Get alerted when new NICOTINAMIDE trials appear

Vitamin B3 trial aims to halt liver damage